Puma biotechnology press release 2025
Puma biotechnology press release 2025
Puma biotechnology press release 2025
Puma biotechnology press release 2025
Puma biotechnology press release 2025
Puma biotechnology press release 2025

Puma biotechnology press release 2025

Puma biotechnology press release 2025, Puma Biotechnology Reports Results of PB272 neratinib in P III 2025

$56.00

SKU: 7381616

Colour
  • Puma Biotechnology
  • Puma Biotechnology Inc. Puma Biotechnology Presents Interim
  • Earnings call Puma Biotechnology reports mixed Q4 results eyes
  • A New Drug on the Horizon for HER2 Breast Cancer Patients Avise
Out of stock
Personalised:
: ( x )
Personalisation:
Edit
Remove Personalisation
Frasers Plus

Buy now.

Pay later.

Earn rewards

Representative APR: 29.9% (variable)

Credit subject to status. Terms apply.

Missed payments may affect your credit score

FrasersPlus